Inflection Point Ventures led the $175,000 pre-seed funding round for Gabify, a healthtech startup that specializes in neurodevelopmental care.
Additionally, the startup received Rs 25 lakh from GHRTBI under the Nidhi Seed Support Scheme.
The money will go toward team growth, technology development, and clinical validation. By 2028, the brand hopes to have an impact on one million children through B2B, B2C, and CSR-led models.
Gabify, an AI-powered platform for early screening and therapy management of speech and neurodevelopmental disorders like autism and ADHD, was founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk.
Based on clinically validated parameters, the platform evaluates speech patterns, facial expressions, and behavioral indicators using a dual AI system that combines voice and vision analysis. Additionally, it uses a human-in-the-loop method for clinical validation.
Schools, hospitals, and clinics use Gabify’s platform, which has been tested in over 35 preschools and daycare facilities.
Gabify is a part of Inflection Point Ventures’ IdeaSchool program and was chosen as one of the top 10 startups under Anupam Mittal’s DreamDeal initiative.
